Medications

FDA approves venetoclax for chronic lymphocytic leukemia

(HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday.

Oncology & Cancer

Impact of COVID-19 infection in blood cancer patients

One of the first studies to investigate the outcome of COVID-19 infection in patients with blood cancer has been conducted by clinical researchers from Queen Mary University of London and Barts Health NHS Trust.

Diabetes

Alcohol poses serious risks for those with diabetes

(HealthDay) -- People who have certain chronic medical conditions, such as type 1 diabetes, are even more susceptible than most to the ill effects of alcohol, though they may not be aware of how potentially dangerous alcohol ...

page 7 from 33